United States · Funded startup

Who invested in Iterion Therapeutics

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcarePharma

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$7.1Mraised across 1 round since 2025, from 1 source

Latest round
Grant, $7.1MNov 2025
Investors
0
See who backed them

The rounds

  1. Nov 2025
    Grant$7.1M

    No investor was named in the report.

    Reported by Lumira Ventures

Founders and team

From Iterion Therapeutics's own website: 3 on the team.

  • Rahul Aras PhDChief Executive Officer
  • Steve Horrigan PhDChief Scientific Officer
  • Iterion TherapeuticsTeam

Also claim to have backed them

These 2 firms list Iterion Therapeutics as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Green Park & Golf VenturesVC firmPer its own site
Portal InnovationsVC firmPer its own site

Quick answers about Iterion Therapeutics

How much has Iterion Therapeutics raised?

Iterion Therapeutics has raised $7.1M across 1 round since 2025.

When did Iterion Therapeutics last raise?

Iterion Therapeutics's most recent round was a Grant of $7.1M in Nov 2025.

What was Iterion Therapeutics's biggest round?

Its most recent round, $7.1M in Nov 2025, is also its largest on record.

What stage is Iterion Therapeutics at?

Iterion Therapeutics's latest named round is a Grant, in Nov 2025.

Where is Iterion Therapeutics based?

Iterion Therapeutics is based in the United States.

Companies like Iterion Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.